Global Oncolytic Virus Therapy Market Size and Forecast 2023-2032| Pfizer Inc., Johnson & Johnson, Sorrento Therapeutics Inc., AbbVie Inc., AstraZeneca plc,

The Oncolytic Virus Therapy Global Market Report 2023, provides comprehensive information on the oncolytic virus therapy market across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa for the 27 major global industries. The report covers a ten year historic period – 2010-2021, and a ten year forecast period – 2023-2032.

Learn More On The Oncolytic Virus Therapy Market’s Growth:

https://www.thebusinessresearchcompany.com/report/oncolytic-virus-therapy-global-market-report

As per The Business Research Company’s Oncolytic Virus Therapy Global Market Report 2023, the global oncolytic virus therapy market is expected to grow from $0.12 billion in 2022 to $0.15 billion in 2023 at a compound annual growth rate (CAGR) of 26.7%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The oncolytic virus therapy market is expected to reach $0.36 billion in 2027 at a CAGR of 24.6%.

Get A Free Sample Of The Report (Includes Graphs And Tables):

https://www.thebusinessresearchcompany.com/sample_request?id=12391&type=sm

Product innovations are a key trend gaining popularity in the oncolytic virus therapy market. Major companies operating in the oncolytic virus therapy market are focused on introducing innovative products to sustain their position in the market. For instance, in November 2021, Daiichi Sankyo Company Limited, a Japan-based pharmaceutical company, launched DELYTACT in Japan. This is the first oncolytic virus approved for primary brain cancer in any region, including genetically engineered oncolytic herpes simplex virus type 1 (HSV-1). The virus selectively replicates and kills tumor cells without affecting normal tissues.

The oncolytic virus therapy market is segmented:

1) By Therapy Type: HSV-Based Oncolytic Virus Therapy, Adenovirus-Based Oncolytic Virus Therapy, Reovirus, Poxviruses, NDV (Newcastle Disease Virus), Other Therapy Types

2) By Virus Type: Genetically Engineered Oncolytic Viruses, Oncolytic Wild-Type Viruses

3) By Application: Breast Cancer, Lung Cancer, Prostate Cancer, Melanoma, Brain Tumor, Blood Cancer

4) By End-User: Hospitals, Specialty Clinics, Cancer Research Institutes

North America was the largest region in the oncolytic virus therapy market in 2022.

The table of contents in TBRC’s oncolytic virus therapy market report includes:

1. Executive Summar

2. Oncolytic Virus Therapy Market Characteristics

3. Oncolytic Virus Therapy Market Trends And Strategies

4. Oncolytic Virus Therapy Market – Macro Economic Scenario

5. Global Oncolytic Virus Therapy Market Size and Growth

.

.

.

26. South America Oncolytic Virus Therapy Market

27. Brazil Oncolytic Virus Therapy Market

28. Middle East Oncolytic Virus Therapy Market

29. Africa Oncolytic Virus Therapy Market

30. Oncolytic Virus Therapy Market Competitive Landscape And Company Profiles

Top Major Players:

• Pfizer Inc
• Johnson & Johnson
• Sorrento Therapeutics Inc
• AbbVie Inc
• AstraZeneca plc

Learn About Us:

The Business Research Company is a market intelligence firm that pioneers in market, company, and consumer research. TBRC’s specialist consultants are located globally and are experts in a wide range of industries that include healthcare, manufacturing, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries. Through the report businesses can gain a thorough understanding of the market’s size, growth rate, major drivers and leading players.

Contact Us:

The Business Research Company

Europe: +44 207 1930 708

Asia: +91 88972 63534

Americas: +1 315 623 0293

Email: info@tbrc.info

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Twitter: https://twitter.com/tbrc_info

Facebook: https://www.facebook.com/TheBusinessResearchCompany

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Blog: https://blog.tbrc.info/

Healthcare Blog: https://healthcareresearchreports.com/

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model